脆弱拟杆菌群临床分离株纸片扩散法药敏试验评估
该研究从韩国三家机构收集150株脆弱拟杆菌群分离株,以琼脂稀释法为参考,评估按EUCAST指南进行的纸片扩散法药敏试验。九种抗菌药物中,亚胺培南、美罗培南、克林霉素和甲硝唑的分类一致率超过90.0%,哌拉西林-他唑巴坦较低为83.2%;使用技术不确定区(ATU)重叠区可减少误差,ATU外头孢西丁、头孢替坦和哌拉西林-他唑巴坦的分类一致率超过90.0%。
要点
- 纸片扩散法可作为脆弱拟杆菌群药敏试验的替代方法
- 亚胺培南、美罗培南、克林霉素和甲硝唑分类一致率超过90.0%
- 应用ATU重叠区可减少纸片扩散法的误差
核心结论
- 纸片扩散法在使用ATU区减少误差时,可作为脆弱拟杆菌群分离株有用的替代药敏试验。
研究设计与样本
- 从韩国三家机构收集150株脆弱拟杆菌群分离株,以CLSI指南琼脂稀释法为参考,按EUCAST指南进行纸片扩散法,使用含5%脱纤维马血的苛养厌氧菌琼脂培养基,评估九种抗菌药物。
主要发现
- 亚胺培南、美罗培南、克林霉素和甲硝唑的分类一致率超过90.0%。
- 哌拉西林-他唑巴坦的分类一致率较低,为83.2%。
- 重大误差:亚胺培南5.4%,美罗培南7.4%,哌拉西林-他唑巴坦12.8%;所有次要误差均低于10%。
- ATU外,头孢西丁、头孢替坦和哌拉西林-他唑巴坦的分类一致率超过90.0%,莫西沙星增至88.5%。
关键数值与推荐
- 分类一致率:亚胺培南、美罗培南、克林霉素和甲硝唑超过90.0%,哌拉西林-他唑巴坦83.2%。
- 重大误差:亚胺培南5.4%,美罗培南7.4%,哌拉西林-他唑巴坦12.8%。
- 所有次要误差均低于10%。
- ATU外分类一致率:头孢西丁、头孢替坦和哌拉西林-他唑巴坦超过90.0%,莫西沙星88.5%。
临床怎么用
- 对脆弱拟杆菌群分离株可考虑采用纸片扩散法药敏试验,并应用ATU重叠区以减少误差。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Bacteroides fragilis group (BFG) isolates are the most frequently isolated gram-negative anaerobic bacteria and exhibit higher levels of antimicrobial resistance than other anaerobic bacteria. Reliable susceptibility testing is needed because of reports of resistance to the most active antibiotics. Recently, the European Committee on Antimicrobial Susceptibility Testing (EUCAST) introduced disk zone diameter breakpoints. We evaluated the disk diffusion test (DDT) for susceptibility testing of BFG isolates compared with the agar dilution method. METHODS: In total, 150 BFG isolates were collected from three institutes in Korea. The agar dilution method was conducted according to the CLSI guidelines. DDT was performed following the EUCAST guideline. Fastidious anaerobe agar supplemented with 5% defibrinated horse blood was used as the culture medium. Nine antimicrobials were evaluated: penicillin, cefoxitin, cefotetan, imipenem, meropenem, piperacillin-tazobactam, clindamycin, moxifloxacin, and metronidazole. RESULTS: The categorical agreement (CA) between the two methods was >90.0% for imipenem, meropenem, clindamycin, and metronidazole. However, the CA for piperacillintazobactam was low, at 83.2%. Major errors were found: 5.4% for imipenem, 7.4% for meropenem, and 12.8% for piperacillin-tazobactam. All minor errors were <10%. We propose using the area of technical uncertainty (ATU) zone-overlapping area for susceptible and resistant strains to reduce errors in the DDT. Outside the ATU, the CAs of cefoxitin, cefotetan, and piperacillin-tazobactam were >90.0%, whereas that of moxifloxacin was increased to 88.5%. CONCLUSIONS: The DDT can be a useful alternative antimicrobial susceptibility test for BFG isolates when using the ATU zone to reduce errors.
引用
- Lee Y, Bae MH, Lee H, et al. Evaluation of the Disk Diffusion Test for Bacteroides fragilis Group Clinical Isolates. Ann Lab Med. 2024. PMID: 39344145. doi:10.3343/alm.2024.0159
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。